Clinical trial financial forecasting

narrowly leads for forecasting clinical trial budgets and costs.

It depends

is also described for forecasting and budgeting in large, complex global studies.

Since Jul 5Updated Nov 14, 2026Based on 59 AI answersReviewed by

How we measure

Brands AI mentions

#BrandMentioned in

Plans and forecasts trial budgets, with site payments tied to real-time visit data.

Forecasts budgets and site payments for large, complex global studies.

Supports end-to-end contract budget management and granular unit-level reporting.

Mentioned in, on ChatGPT and Google AI Mode

Questions and answers

  • Google AI ModeNov 3, 2026

    1. 1Medidata Clinical Trial Financial Management (CTFM)
    2. 2Medidata Rave
    3. 3Clinical Maestro
    4. 4Greenphire
    5. 5eClinicalGPS
    6. 6IQVIA Clinical Trial Financial Suite

    Managing finances, budgeting, and forecasting for clinical trials—from single-center studies to complex, multi-region global programs—requires specialized Clinical Trial Financial Management (CTFM) or integrated eClinical software . These tools replace error-prone spreadsheets with benchmark data, scenario modeling, and automated site payments.

    Leading software solutions designed for clinical trial financial planning and forecasting include:

    • Medidata Clinical Trial Financial Management (CTFM) : Part of the Medidata Rave platform, this end-to-end suite handles everything from initial budget planning and Fair Market Value (FMV) benchmarking (via Rave Grants Manager ) to automated site payments and real-time accrual forecasting. It is widely adopted by both large pharmaceutical sponsors and Contract Research Organizations (CROs). Learn more on the Medidata Financial Management Page.
    • IQVIA Clinical Trial Financial Solutions (CTFS) : A unified, AI-driven platform designed for budgeting, contracting, and forecasting. It scales seamlessly for large global programs, leveraging IQVIA's massive proprietary database of global site costs and healthcare data to drive predictive forecasting and optimized budget negotiations.
    • Strategikon Clinical Maestro : A cloud-based platform specifically built to streamline clinical operations and financial sourcing. It accelerates Request for Proposal (RFP) creation, vendor selection, and study budget forecasting by up to 10x, making it popular for both mid-size biotech and enterprise forecasting.
    • Greenphire (eClinicalGPS) : While specialized heavily in site payment automation and global disbursements, Greenphire integrates financial tracking with robust forecasting data regarding site burden and milestone-driven cash flow across thousands of global studies. Check out details on the Greenphire Official Website.

    If you'd like to narrow down the choice, let me know:

    • Are you looking for a solution as a Sponsor, CRO, or investigative site?
    • Do you need an end-to-end suite (including site payments) or strictly budgeting and forecasting analytics?

    ChatGPTNov 3, 2026

    1. 1IQVIA Clinical Trial Financial Suite
    2. 2Insite
    3. 3Auxilius
    4. 4Condor Software
    5. 5Clinical Maestro
    6. 6Trialytix
    7. 7Cloudbyz
    8. 8Anaplan
    9. 9Workday Adaptive Planning
    10. 10Oracle
    11. 11SAP Analytics Cloud
    12. 12IBM Planning Analytics
    13. 13Intelia Clinical Trial Planning
    14. 14Medidata Clinical Trial Financial Management (CTFM)
    15. 15Suvoda IRT Clinical Trial
    16. 16LedgerRun

    Several specialized software platforms can support clinical trial financial planning, budgeting, cost management, and forecasting, from an individual study to a multinational clinical development portfolio.

    The most relevant options fall into three categories:

    1. Purpose-built clinical trial financial management: Study budgets, investigator grants, site payments, contracts, and financial forecasts.
    2. Clinical development planning and portfolio forecasting: Study scenario modeling, enrollment assumptions, country-level costs, and total R&D expenditure.
    3. Financial planning and analysis (FP&A): Consolidated budgets, actual-versus-forecast reporting, resource planning, and enterprise financial management.

    Below is a comparison of the leading options I found, based on their publicly described capabilities as of November 2026.

    1. Specialized clinical trial financial software

    • CTFS GrantPlan | IQVIA

    1. IQVIA Clinical Trial Financial Suite (CTFS)

    (Strong enterprise option)

    • Study and investigator grant budgeting.
    • Global site cost benchmarking.
    • Financial forecasting.
    • Site and participant payments.
    • Contract management and financial reporting.

    Particularly relevant for large sponsors and global clinical programs.

    Website:

    www.iqvia.comwww.iqvia.com


    • Clinical Trial Budget Software | TrialCast by Caladan

    2. PSI INTELIA

    • CLARITY: Study budgeting and forecasting.
    • CADENCE: Budget tracking and reporting.
    • INSITE: Investigator grant calculator.
    • VISIONAL: Clinical feasibility and financial modeling.

    Particularly interesting for study-level planning and forecasting across multiple studies.

    Website:

    psi-cro.compsi-cro.com


    • Auxilius: R&D Accrual & Forecast Automation for Biopharma

    3. Auxilius

    • Clinical trial budgeting and forecasting.
    • Study cost benchmarking.
    • Scenario modeling by indication, phase, enrollment, and geography.
    • R&D accrual automation.
    • Financial close and investigator spend intelligence.

    Particularly suitable for biotech and pharmaceutical companies looking to connect clinical operations with R&D finance.

    Website:

    www.auxilius.cowww.auxilius.co


    • Clinical Trial Finance Software for Biopharma | Condor

    4. Condor Software

    • Driver-based financial forecasting.
    • Dynamic scenario modeling.
    • Investigator grant forecasting.
    • Vendor projections versus actual spending.
    • Portfolio-wide financial visibility.
    • ERP integration.

    A particularly relevant option for financial planning and analysis across a clinical development portfolio.

    Website:

    condorsoftware.com


    • Clinical Maestro 2.4 Brings New Speed and Agility to Clinical Trial Budgeting and Outsourcing

    5. Strategikon Clinical Maestro

    • Clinical trial budgeting.
    • CRO and vendor sourcing.
    • Proposal automation.
    • Vendor qualification and management.
    • Budget planning and outsourcing oversight.

    Worth evaluating for sponsors and CROs managing outsourced clinical programs.

    Website:

    www.iqvia.comwww.iqvia.compsi-cro.compsi-cro.comwww.auxilius.cowww.auxilius.cocondorsoftware.comwww.cbinsights.comwww.actitime.comwww.diligentpharma.com

    2. Additional clinical trial budgeting and financial management tools

    SoftwareMain capabilitiesBest suited for
    Medidata Clinical Trial Financial ManagementStudy budgeting, financial workflows, and integration with clinical trial dataSponsors using Medidata's ecosystem
    Suvoda BudgetingBudgeting, benchmarking, site paymentsSponsors needing budgeting and payment management
    TrialytixParameter-driven clinical trial budget calculationsCROs, pharma, and academic research
    Cloudbyz CTFMClinical trial financial management on SalesforceSmall and mid-sized biotech companies
    Ledger Run ClinRunSite budgets, contracting, payments, and forecastingIntegrated site financial operations

    These options are identified in a 2026 clinical trial budget software comparison.

    3. Enterprise financial planning platforms

    If the requirement extends beyond individual study budgets to managing the overall financial position of a clinical development organization, general-purpose FP&A platforms can also be relevant.

    SoftwarePotential application
    AnaplanMulti-study financial modeling, scenario planning, resource allocation
    Workday Adaptive PlanningDepartmental budgets, workforce planning, financial forecasts
    Oracle Cloud EPMEnterprise budgeting, forecasting, consolidation
    SAP Analytics CloudFinancial planning, reporting, and scenario analysis
    IBM Planning AnalyticsComplex financial models, resource planning, and forecasting

    These are general enterprise planning platforms rather than specialized clinical trial budgeting systems. They may require configuration or integration with CTMS, ERP, and clinical operations data.

    4. Comparison by organizational requirements

    SoftwareSingle studyMultiple studiesGlobal programsFinancial forecasting
    IQVIA CTFSExcellentExcellentExcellentExcellent
    PSI INTELIAExcellentExcellentStrongExcellent
    AuxiliusExcellentExcellentStrongExcellent
    CondorStrongExcellentExcellentExcellent
    Clinical MaestroStrongExcellentStrongStrong
    Medidata CTFMStrongExcellentStrongStrong
    SuvodaStrongExcellentStrongStrong
    Enterprise FP&A platformsStrongExcellentExcellentExcellent

    These are qualitative assessments of product positioning and advertised capabilities, not independent benchmark scores.

    5. My recommendations: which platforms should you shortlist?

    For an organization looking to manage clinical trial finances from a single study through a global portfolio, I would prioritize these five:

    (Best overall clinical financial management)

    IQVIA Clinical Trial Financial Suite

    Best starting point for comprehensive study budgeting, global site costs, contracting, forecasting, and payments.


    (Best for study planning and modeling)

    PSI INTELIA

    Particularly interesting for modeling study scenarios, enrollment assumptions, feasibility, and budgets.


    (Best for biotech R&D finance)

    Auxilius

    Strong candidate for connecting study budgets, actual expenses, accruals, and forecasts.


    (Best for portfolio-level forecasting)

    Condor Software

    Worth investigating for consolidated clinical program financial forecasts and scenario modeling.


    (Best for enterprise-wide planning)

    Anaplan

    Useful when clinical trial budgets need to feed into broader corporate financial planning and resource allocation.

    6. Important capabilities to evaluate before selecting software

    For clinical trial financial planning, I would assess whether the platform supports:

    • Study budgeting: Phase I–IV budgets, protocols, activities, visits, and cost assumptions.
    • Country-level budgeting: Regional cost differences, currency conversion, and local site costs.
    • Scenario planning: Changes in patient enrollment, number of sites, study duration, and recruitment timelines.
    • Portfolio forecasting: Consolidated financial projections across studies, indications, and therapeutic areas.
    • Actual versus budget: Tracking commitments, invoices, payments, accruals, and variances.
    • CRO and vendor management: Contract values, change orders, milestone payments, and vendor forecasts.
    • Resource planning: Clinical operations staffing, FTEs, and resource allocation.
    • Integration: CTMS, EDC, ERP, procurement, and accounting systems.
    • Auditability: Approval workflows, version control, traceability, and financial controls.

    One important distinction: A clinical trial budgeting tool is not necessarily a complete financial planning system. If you need both operational study-level costing and consolidated corporate forecasting, you may need two integrated platforms.


    7. A question that would help narrow down the best solution

    Are you primarily looking for software for:

    A. Pharmaceutical/biotech sponsors – managing clinical trial budgets, forecasts, actuals, and financial commitments across a development portfolio.

    B. CROs – planning study costs, managing client budgets, resource utilization, project profitability, and revenue forecasts.

    C. Hospitals or clinical research institutions – budgeting individual studies, investigator grants, research staff, and departmental finances.

    D. Enterprise clinical development finance – managing financial planning, budgeting, forecasting, and scenario analysis across global clinical programs and multiple therapeutic areas.

    I can use your answer to narrow this down to the 5–7 most appropriate platforms, including a comparison of functionality, scalability, integrations, and suitability for global clinical trial financial management.

  • ChatGPTOct 17, 2026

    1. 1Medidata Clinical Trial Financial Management (CTFM)
    2. 2IQVIA Clinical Trial Financial Suite
    3. 3Veeva Vault CTMS
    4. 4Oracle
    5. 5Planful

    For multi-year clinical trials, I’d prioritize platforms that can calculate forecast-to-complete (the remaining cost from today through trial closeout) rather than simply compare spending against the original budget. The best fit depends on whether you need site-payment forecasting, operationally driven cost projections, or portfolio-level financial planning.

    My initial shortlist is Medidata Clinical Trial Financial Management (CTFM), IQVIA Clinical Trial Financial Suite (CTFS), Veeva Vault CTMS, and Oracle’s clinical/finance ecosystem, with Planful worth considering if enterprise financial planning is a major requirement alongside your CTMS. These products have different strengths, and not all offer the same depth of clinical-specific forecasting.

    Top options to evaluate

    • Clinical Trial Financial Management Software - Rave CTFM

    1. Medidata Clinical Trial Financial Management (CTFM)

    (Best overall starting point)

    Best for: Sponsors and CROs needing forecasts tied to study activity.

    Medidata connects budgeting, site negotiations, payment workflows, forecasting, and accrual tracking. Its financial forecasts can incorporate current study activity and historical cost data as enrollment, timelines, and protocols change. Scenario planning is also available through its financial management tools.

    Validate: remaining-cost projections across sites, vendors, and non-site expenses, not just grant payments.

    Product details


    • CTFS GrantPlan | IQVIA

    2. IQVIA Clinical Trial Financial Suite (CTFS)

    Best for: Large, global trial portfolios with complex site budgets and financial workflows.

    Put IQVIA on the shortlist if you manage many countries, sites, currencies, and payment obligations. Its clinical-trial financial tools are worth evaluating for grant planning, budget control, and payment management.

    Validate: how the proposed solution calculates estimate-at-completion (EAC), outstanding commitments, accruals, and forecast-versus-actual variance.

    IQVIA website


    • Veeva Payments | Veeva

    3. Veeva Vault CTMS

    Best for: Teams prioritizing unified clinical operations and financial visibility.

    A strong candidate if you want trial-management workflows and payment information connected to the broader clinical operations environment. Veeva merits consideration when it fits your existing systems and operating model.

    Validate carefully: a budget-versus-actual report is not the same as a dynamic projection of all costs remaining through closeout.

    Veeva website


    • Oracle Clinical Development Analytics (CDA) for Siebel CTMS | Clinic, Development, Analytics

    4. Oracle clinical and finance ecosystem

    Best for: Enterprises with substantial Oracle infrastructure.

    Consider the clinical operations platform alongside your existing ERP and financial planning systems if you need enterprise reporting and consolidated financial oversight across a portfolio.

    Validate: whether the forecast is calculated inside the clinical platform or requires integration and custom financial models.

    Oracle website


    • Hypha Clinical: Clinical payments. Finally under control.

    5. Planful

    Best for: Portfolio-level budgeting, scenario analysis, and finance-led forecasting.

    Planful offers clinical-trial cost models organized by development stage, site, and enrollment drivers. Its approach is particularly relevant when finance needs to reforecast as enrollment assumptions and site timelines change.

    Important distinction: Planful is a financial planning platform, not a replacement for a full clinical CTMS. Assess the integration required to bring in operational data.

    Clinical trial planning details

    What matters most for your use case

    I would score each vendor against these capabilities before making a decision. These are evaluation criteria, not independently verified feature scores for every vendor.

    CapabilityPriorityWhat to demonstrate
    Forecast-to-complete / EACCriticalProject total cost from today through closeout
    Enrollment-driven forecastingCriticalRecalculate patient, visit, and site costs as enrollment changes
    Accruals and commitmentsCriticalInclude incurred-but-unpaid costs and contracted future obligations
    Scenario modelingHighModel delays, slower recruitment, added sites, and protocol amendments
    Multi-year cost assumptionsHighAccount for inflation, exchange rates, and changing vendor rates
    Portfolio reportingHighRoll up remaining costs across trials, countries, and fiscal years
    Finance-system integrationHighReconcile forecasts with actual spend from your ERP or accounting system

    The most important distinction: budget remaining vs. cost remaining

    A CTMS may show a large unspent budget even when a study is likely to exceed its original estimate. You need a forward-looking model that accounts for both committed and expected costs.

    A useful forecast should approximate:

    math
    \begin{aligned}
    \text{Cost to complete} ={}&
    \text{Expected future costs}\\
    &+ \text{Outstanding obligations}\\
    &+ \text{Unpaid accrued costs}\\
    &+ \text{Expected change costs}
    \end{aligned}

    Avoid double-counting accrued or committed expenses when building the model. Your vendor should explain exactly how each category is treated.

    My recommendation

    • Start with Medidata CTFM if you want clinical activity, site budgets, payments, and forecasting connected in one environment.
    • Evaluate IQVIA CTFS alongside it if you have a large, multinational portfolio and finance complexity is the main driver.
    • Include Planful if your bigger challenge is consolidated forecasting across clinical programs and corporate finance, rather than clinical operations alone.

    These are a requirements-based shortlist, not a definitive independent ranking. Public product descriptions do not establish that every vendor can calculate a fully integrated, portfolio-wide remaining-cost forecast without configuration or additional modules.

    For vendor demonstrations, ask each company to forecast a real or representative study with a recruitment delay, a protocol amendment, currency changes, and outstanding site payments—and show how the projected final cost changes.

    One question to narrow the shortlist

    Are you primarily a pharma/biotech sponsor, a CRO, or a clinical research site/network? That will help determine which products are the strongest fit for your organization and its financial workflows.

    Google AI ModeOct 17, 2026

    1. 1Medidata Clinical Trial Financial Management (CTFM)
    2. 2Medidata Rave
    3. 3IQVIA Clinical Trial Financial Suite
    4. 4GrantPlan
    5. 5Clinical Maestro
    6. 6LEAD
    7. 7Veeva Vault CTMS
    8. 8Medidata Payments

    For multi-year clinical trials, managing burn rates, shifting enrollment timelines, and site-level milestone costs requires specialized Clinical Trial Financial Management (CTFM) or robust CTMS integration rather than basic tracking.

    The top industry options that excel at projecting remaining expenses, scenario modeling, and dynamic financial forecasting include:

    1. Medidata Clinical Trial Financial Management (CTFM)
      • Overview: Part of the Medidata Rave platform, CTFM connects clinical operations with financial execution. It utilizes Rave Grants Manager and Rave Site Payments.
      • Forecasting Strengths: It links operational data (like actual patient enrollment and EDC milestone triggers) directly to financial forecasts. As study timelines or recruitment rates shift, Medidata’s predictive algorithms and Fair Market Value (FMV) benchmarks dynamically recalculate projected remaining expenses and accruals.
    2. IQVIA Clinical Trial Financial Suite (CTFS)
      • Overview: An enterprise, AI-powered suite designed to unify budgeting, contracting, forecasting, and global site/participant payments.
      • Forecasting Strengths: Backed by massive proprietary datasets (millions of negotiated data points via GrantPlan ), the IQVIA Clinical Trial Financial Suite models complex multi-year variances. It provides robust forecasting modules that accommodate multi-currency global footprints and align operational milestones with upcoming cash flow needs.
    3. Strategikon Clinical Maestro
      • Overview: A cloud-based SaaS platform built specifically to streamline R&D procurement, budgeting, and financial modeling. It operates via modular components like Portfolio and Lead.
      • Forecasting Strengths: Clinical Maestro replaces complex, error-prone manual spreadsheets with automated unit-level tracking and Earned Value Analysis. It excels at real-time scenario planning, letting finance teams instantly see how protocol amendments, vendor rate changes, or enrollment delays impact remaining trial costs across a multi-year horizon.
    4. Veeva Vault CTMS (with Financial/Budgeting Extensions)
      • Overview: Veeva is a dominant operational CTMS that integrates tightly with clinical financial partners or native budget tracking tools.
      • Forecasting Strengths: While Veeva acts as the single source of truth for trial operations, it pairs with financial lifecycle tools to track visit-driven costs and operational progress. It is ideal if your priority is keeping operational milestones (monitoring visits, site activation) locked in sync with the financial forecast.

    To help narrow down which choice fits best, tell me:

    • Are you looking for a standalone financial platform that syncs with your current CTMS, or an all-in-one suite?
    • Roughly how many active, multi-year protocols are you managing simultaneously?
  • Google AI ModeNov 9, 2026

    1. 1IQVIA Clinical Trial Financial Suite
    2. 2GrantPlan
    3. 3Greenphire Clinical Finance
    4. 4eClinicalGPS
    5. 5Medidata Clinical Trial Financial Management (CTFM)
    6. 6Sage Intacct
    7. 7Workday Adaptive Planning

    Managing clinical trial budgets from a single proof-of-concept study up to a sprawling, multi-region global program requires specialized eClinical financial tools (often integrated into a Clinical Trial Management System or a dedicated Clinical Trial Financial Suite).

    The top enterprise-grade options scale smoothly across single or multi-study pipelines:

    1. IQVIA Clinical Trial Financial Suite (CTFS)

    • Best For: Large-scale, global biopharma programs and enterprise rollouts.
    • Core Modules:
      • GrantPlan: Uses massive global benchmark datasets (millions of negotiated data points and fair market value (FMV) insights across 175+ countries).
      • Contracting & Forecasting: Connects site-sponsor agreements directly to predictive payment modeling and live accruals.
      • Site & Participant Payments: Automates global disbursements with built-in multi-currency and tax compliance.
    • Scaling: Built to handle everything from a phase I study to a portfolio of hundreds of simultaneous global trials. Learn more via the IQVIA Clinical Trial Financial Suite.

    2. Greenphire Clinical Finance (via Suvoda)

    • Best For: Streamlining budget creation, site negotiations, and transparent site disbursements.
    • Core Modules:
      • EnvisiX / Budgeting & Benchmarking: Intuitive spreadsheet-like builder that ingests protocols/Schedules of Assessments to create defensible, FMV-backed country and site budgets.
      • eClinicalGPS: Long-standing site payment engine tying automated disbursements directly to live study data/milestones.
    • Scaling: Strong track record supporting mid-size to massive global sponsors operating across dozens of countries. Explore details in the Greenphire Clinical Finance Overview.

    3. Medidata Clinical Trial Financial Management (CTFM)

    • Best For: Unified ecosystems where you want clinical data (EDC) and financial workflows tightly coupled.
    • Core Modules:
      • Grants Manager: Built-in FMV benchmarks and scenario planning to model cost drivers early.
      • Forecasting & Accrual Tracking: Dynamically adjusts spend risk visibility as protocol amendments, timelines, or patient enrollment numbers shift.
      • Site Payments: Real-time calculations derived straight from live EDC activity.
    • Scaling: Seamlessly bridges single-study execution with enterprise-wide clinical program oversight. Check out the Medidata Clinical Trial Financial Management Page.

    4. Specialized Life Sciences ERP/FP&A (e.g., Sage Intacct for Life Sciences or Workday Adaptive Planning)

    • Best For: High-level corporate financial forecasting, multi-entity fund accounting, and R&D burn-rate rollups that sit above the operational site-payment layer.
    • Core Capabilities: Native grant accounting, complex research cost allocation, and multi-currency consolidation.
    • Scaling: Ideal if you need to tie individual clinical trial models back into the company’s general ledger and investor reporting. Look into Sage Intacct for Biotech & Life Sciences.

    Comparison at a Glance

    Tool / SuitePrimary StrengthGlobal / FMV Benchmark DataSite Payment AutomationBest Fit
    IQVIA CTFSDeepest historical data pool & AI analyticsYes (175+ countries)Comprehensive (Site & Participant)Top pharma / massive global portfolios
    GreenphireUser-friendly budget building & site trustYes (70+ countries)Industry-standard (eClinicalGPS)Sponsors prioritizing site relationship/transparency
    Medidata CTFMTight native link to EDC & protocol changesYes (Grants Manager)Tied to live study activityTeams already embedded in the Medidata ecosystem
    Sage IntacctCorporate ledger, R&D tracking, & FP&AFund/Grant levelAccounts payable / ERP-focusedFinance teams managing overall company burn & audit

    To help narrow down the best fit, could you share:

    • What phase or size are your current studies (e.g., a single Phase I trial vs. 15 active global trials)?
    • Do you need the tool to directly handle site payments and investigator grants , or are you primarily focused on high-level corporate budgeting and forecasting?

    ChatGPTNov 9, 2026

    1. 1IQVIA Clinical Trial Financial Suite
    2. 2Condor Software
    3. 3Auxilius Atlas
    4. 4Trialytix
    5. 5Cloudbyz
    6. 6Clinical Maestro
    7. 7TrialEngine
    8. 8Medidata Clinical Trial Financial Management (CTFM)
    9. 9Suvoda IRT Clinical Trial

    If you need clinical trial budget management that can grow from a single-study environment to a multinational clinical development portfolio, I'd focus on purpose-built Clinical Trial Financial Management (CTFM) and R&D financial planning platforms rather than generic budgeting software.

    There are several strong options, but they solve slightly different problems. Some specialize in investigator grant budgets and site payments; others are better at forecasting total study costs, managing CRO spend, and consolidating financial forecasts across global programs.

    1. Leading software options

    Here is the shortlist I'd evaluate for your requirements.

    • CTFS GrantPlan | IQVIA

    1. IQVIA Clinical Trial Financial Suite

    (Enterprise / global scale)

    • Study budgeting and investigator grant negotiation.
    • Global fair-market-value (FMV) benchmarks.
    • Forecasting, contracting, site and participant payments.
    • Portfolio-wide financial management.

    Best for: Large sponsors and CROs managing multiple studies across countries.

    Source: IQVIA official product overview ·


    • Clinical Trial Finance Software for Biopharma | Condor

    2. Condor Software

    (Strong forecasting focus)

    • Driver-based financial forecasting.
    • Portfolio, program, study and line-item visibility.
    • Budget-versus-actual analysis.
    • What-if scenario modeling.
    • ERP, EDC and CTMS integrations.

    Best for: Organizations that need consolidated financial forecasting and ongoing financial control across their R&D portfolio.

    Source:


    • Clinical Trial Financial Management Software - Rave CTFM

    3. Medidata Clinical Trial Financial Management

    • Investigator grant budgeting and negotiation.
    • FMV benchmarking.
    • Forecasting based on enrollment and protocol changes.
    • Site payments and financial tracking.
    • Integration with the broader Medidata ecosystem.

    Best for: Sponsors already using Medidata CTMS, EDC or Rave.

    Source:


    • Auxilius: R&D Accrual & Forecast Automation for Biopharma

    4. Auxilius Atlas

    (Excellent study planning candidate)

    • Estimate study costs before committing.
    • Scenario modeling based on enrollment, geography and site mix.
    • Real-world cost benchmarking.
    • Budget generation from schedules of assessments.
    • Portfolio-level cost forecasting.

    Best for: Biotechs planning new studies and comparing financial implications of different study designs.

    Source:


    • Trialytix | Trialytix for Pharma

    5. Trialytix

    • Study budget control and actual expenditure.
    • Cash-flow and payment forecasting.
    • Internal and external cost tracking.
    • Portfolio dashboards.
    • Department-level utilization and reporting.

    Best for: Smaller and growing organizations wanting visibility into study-level finances and portfolio expenditure.

    Source:


    • Clinical Trial Technology for CROs | Suvoda

    6. Suvoda Budgeting and Benchmarking

    • Study and site budget creation.
    • Global cost benchmarks.
    • Site payment workflow integration.
    • Budget negotiation support.

    Best for: Sponsors prioritizing site budgeting, benchmarking and payments across international studies.

    Source:

    2. Other platforms worth considering

    These are particularly relevant if you want alternatives to the larger enterprise platforms.

    PlatformMain strengthBest fit
    Cloudbyz CTFMBudgeting, forecasting, reconciliation and grant administrationMid-sized biotech
    Strategikon Clinical MaestroCRO/vendor budgeting, bid management and change ordersOutsourced clinical operations
    Research Grid TrialEngineProtocol-based budgeting, cash-flow forecasting and financial reportingSponsors, CROs and research sites

    Sources: Clinical trial software comparison and Research Grid TrialEngine.

    3. Comparison against your scaling requirements

    This is my qualitative assessment of where I'd concentrate the evaluation. It is not a verified feature-by-feature vendor scorecard.

    CapabilityPlatforms to prioritize
    Single-study budgetingAuxilius, Trialytix, IQVIA
    Multiple-study managementCondor, IQVIA, Trialytix
    Global program managementIQVIA, Medidata, Condor
    Financial forecastingCondor, Auxilius, Trialytix
    Scenario / what-if analysisCondor, Auxilius
    Investigator grant managementIQVIA, Medidata, Suvoda
    CRO and vendor cost controlCondor, Strategikon
    Budget versus actualsCondor, Trialytix
    Site paymentsIQVIA, Medidata, Suvoda

    My initial recommendations

    I'd narrow the field to four:

    1. IQVIA – strongest starting point for comprehensive global clinical trial financial management.
    2. Condor – particularly compelling for financial forecasting, scenario planning and portfolio-wide visibility.
    3. Auxilius – worth evaluating for study planning, early-stage cost estimation and financial scenario analysis.
    4. Medidata – particularly attractive if your clinical operations infrastructure already uses Medidata.

    One important distinction: a system that manages investigator grants and site payments isn't necessarily a complete financial planning and analysis (FP&A) system. If you want to forecast the financial performance of entire development programs, you need visibility beyond site budgets.

    4. What I'd insist on in a vendor evaluation

    For a platform intended to scale internationally, I'd make these capabilities mandatory:

    • Hierarchical budgeting: Study → country → site → vendor → cost category → line item.
    • Portfolio consolidation: Roll multiple studies into programs and global development portfolios.
    • Dynamic forecasting: Automatically adjust forecasts for enrollment, recruitment delays, amendments, study duration and site activation.
    • Scenario planning: Best case, base case and worst case, with adjustable assumptions.
    • Actuals and accruals: Compare approved budgets, commitments, actual expenditure and forecast-at-completion.
    • Multi-currency support: Local currencies, exchange rates and consolidated reporting currency.
    • Integration: ERP, CTMS, EDC, procurement and accounting systems.
    • Governance: Audit trails, permissions, approvals, version control and financial reporting.

    5. Suggested evaluation priorities

    I'd use a weighted scorecard when comparing vendors:

    Evaluation areaWeight
    Financial forecasting and scenario modeling25%
    Study and portfolio budgeting20%
    Global scalability and currencies15%
    Budget versus actuals and accruals15%
    Integrations and data architecture10%
    Reporting and dashboards10%
    Implementation and usability5%
    Total100%

    Ask each vendor to demonstrate the same scenario: one study with multiple countries, several sites per country, multiple CROs, a protocol amendment, delayed enrollment and an updated forecast across the entire portfolio.

    That will quickly distinguish genuine financial management platforms from tools that primarily generate study budgets.


    6. A few questions to narrow this down

    The biggest decision is whether you need a clinical trial budgeting tool or a broader clinical development financial management platform.

    What type of organization will be using the system?

    1. Organization type

    Biotech / pharmaceutical sponsor

    Contract Research Organization (CRO)

    Academic / research institution

    Multiple sponsors / global clinical operations


    2. Expected scale

    One or two studies

    Growing from 1–5 studies to 20+

    20–100 concurrent studies

    100+ studies across global programs


    3. Primary requirement

    Study budget creation and management

    Financial forecasting and scenario planning

    Full financial management and forecasting

    Enterprise portfolio-level R&D financial planning


    4. Deployment preference

    Cloud / SaaS

    Enterprise hosted

    No preference

    [Find my best-fit platforms]

    With those answers, I can produce a more targeted shortlist of vendors, compare their capabilities, identify potential gaps and recommend which three or four are worth taking into a formal software procurement process.

  • ChatGPTSep 23, 2026

    1. 1Medidata
    2. 2IQVIA Clinical Trial Financial Suite
    3. 3Oracle
    4. 4Veeva Vault CTMS

    If the primary question is “How much will this study cost to finish from where we are today?”, I’d focus on clinical-financial platforms with true forecast-to-complete/EAC, accruals, commitments, and scenario modeling—not just CTMS budget-vs.-actual dashboards.

    My shortlist

    PlatformRemaining-cost forecastingScenario modelingAccrual / commitment visibilityParticularly strong when…
    Medidata CTFMExcellentExcellentExcellentYou want forecasts tightly connected to study execution
    IQVIA Clinical Trial Financial SuiteExcellentExcellentExcellentYou have large/global studies and complex financial operations
    Oracle clinical + finance ecosystemVery goodVery goodStrongYour organization is heavily standardized on Oracle
    Veeva Vault CTMS / financial productsGood–very goodGoodGoodYou're already deeply invested in Veeva

    Medidata CTFM

    For your specific use case, Medidata Clinical Trial Financial Management (CTFM) is probably the first product I'd put through a detailed evaluation.

    Medidata says CTFM supports ongoing forecasting and accrual tracking using current study activity and historical cost data, with forecasts adjusting as enrollment, timelines, and protocols change. That is exactly the mechanism you want for estimating remaining costs on a multi-year study.

    Its Grants Manager also adds scenario planning and analytics around changes to timelines, regions and study design, including variables such as inflation and exchange rates.

    medidata.com

    IQVIA CTFS

    I'd put IQVIA Clinical Trial Financial Suite alongside Medidata in the evaluation. Its main attraction is that it's a dedicated clinical-financial platform rather than merely financial reporting bolted onto a CTMS.

    For a large multinational study, I'd specifically investigate its ability to forecast:

    • Remaining site payments
    • CRO/vendor commitments
    • Accrued but unbilled costs
    • Enrollment-driven future costs
    • Country-level and site-level spend
    • Timeline extensions
    • Future cash requirements

    What I would demand in the vendor demo

    Give every vendor the same live forecasting scenario:

    You're 30 months into a 5-year study. Enrollment is running 20% slower than planned. The study will extend six months, 15 sites are being added, a protocol amendment adds two visits per patient, and several completed sites haven't invoiced yet. Then ask the system to recalculate:

    1. Remaining cost to complete
    2. Estimate at completion (EAC)
    3. Actual vs. accrued vs. committed vs. forecasted spend
    4. Site/country/vendor-level remaining costs
    5. Monthly/quarterly cash forecast
    6. Effect of enrollment-rate changes
    7. Effect of protocol amendments
    8. What-if scenarios
    9. Forecast version history/audit trail
    10. The operational assumptions driving every major forecast

    That last point is particularly important. A system can have beautiful financial dashboards while still requiring finance staff to manually construct the actual forecast.

    My practical takeaway

    For study-level remaining-cost forecasting, I'd put Medidata CTFM and IQVIA CTFS through the same RFP process. Medidata has a particularly clear story around connecting current study activity to forecasting and accruals; IQVIA deserves equal consideration if you have large, complex global financial operations.

    If you tell me (a) sponsor vs. CRO, (b) approximate number of sites/patients, and (c) your current EDC/CTMS/ERP, I can turn this into a 10–15 criterion vendor scorecard specifically for remaining-cost forecasting, including integration, implementation, scenario modeling, accruals, and TCO.

    Google AI ModeSep 23, 2026

    1. 1IQVIA Clinical Trial Financial Suite
    2. 2Veeva Vault CTMS
    3. 3Veeva eTMF
    4. 4Medidata Rave CTMS
    5. 5Medidata Rave
    6. 6RealTime eClinical Solutions

    When managing multi-year clinical trials, estimating remaining costs requires a platform that bridges operational milestones (patient accrual, site activation, visits completed) with financial tracking (grant planning, site payments, and pass-through costs).

    The top solutions recognized for advanced financial forecasting and budget lifecycle management include:

    • IQVIA Clinical Trial Financial Suite (CTFS): Specifically built to unify budgeting, contracting, forecasting, and site payments. IQVIA’s forecasting module is tailored for complex, global multi-year studies, utilizing integrated data to predict site payment trajectories, adjust for currency fluctuations, and model future financial burn rates against actual milestone progress.
    • Veeva Vault CTMS (with Veeva Payments): Best for enterprise sponsors and CROs running unified clinical operations. Veeva allows you to define planned budget amounts, map them against external models, and track actual spend across studies, countries, and sites via Veeva Payments. Its strength lies in real-time operational data from the broader Vault Clinical suite driving the financial forecasts accurately.
    • Medidata CTMS / Rave Clinical Data Stack: Highly regarded when electronic data capture (EDC) is the center of gravity. Medidata benefits from massive real-world cost data benchmarking and historical datasets, which helps project remaining per-patient and site costs with high statistical reliability over a multi-year timeline.
    • RealTime CTMS: A strong contender if your multi-year study heavily involves site networks or hybrid/complex site budgeting. It features robust, intuitive native accounting tools specifically designed to track subject visits against investigator fee schedules dynamically.

    To help narrow down which of these platforms fits your organization best, could you tell me:

    • Are you operating as a sponsor, a CRO, or a large site network?
    • Do you need the financial forecasting tool to integrate with a specific EDC or ERP system (like SAP or Oracle Financials)?